Felix Baker

Dr. Felix J.
Baker is an Independent Non-Executive Director at BeOne Medicines Ltd., a Lead Independent Director at Kiniksa Pharmaceuticals International Plc, a Non-Executive Chairman at Bicycle Therapeutics Plc, a Chairman at Kymera Therapeutics, Inc., a Lead Independent Director at Kiniksa Pharmaceuticals Ltd., an Independent Director at Kodiak Sciences, Inc., a Managing Member at Baker Bros.
Advisors LP, a Co-Managing Partner at Baker Bros.
Advisors GP LLC, a Manager at Fbb2 LLC and a Partner at FBB Associates.
He is on the Board of Directors at BeOne Medicines Ltd., Kiniksa Pharmaceuticals International Plc, Kiniksa Pharmaceuticals Ltd., Kodiak Sciences, Inc., Kiniksa Pharmaceuticals Corp., N-Power Medicine, Inc. and Memorial Sloan Kettering Cancer Center.
Dr. Baker was previously employed as an Independent Director by IGM Biosciences, Inc., an Independent Director by Alexion Pharmaceuticals, Inc., a Chairman by Talis Biomedical Corp., an Independent Director by Genomic Health, Inc., an Independent Director by Ardea Biosciences, Inc., a Chairman by Seagen, Inc., a Chairman by Synageva BioPharma Corp., and an Owner by VaxGen, Inc. He also served on the board at Trimeris, Inc., ConjuChem Biotechnologies, Inc. /Old/, Neurogen Corp., ConjuChem, Inc., AnorMED, Inc., Aquinox Pharmaceuticals, Inc., ConjuChem Biotechnologies, Inc., Presidio Pharmaceuticals, Inc. and SlipChip Corp.
He received his undergraduate degree from Stanford University and a doctorate degree from Stanford University.